Kiniksa Pharmaceuticals Ltd (KNSA) Insider Trading
- $71,248,379.44
- $52,068,434.78
- Feb. 12, 2026
- Eben Tessari
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Feb. 12, 2026 | Director | 2,690 | $45.00 | Sell | $121,050.00 | |
| Feb. 10, 2026 | Director | 110 | $45.00 | Sell | $4,950.00 | |
| Feb. 9, 2026 | CFO | 17,845 | $43.28 | Sell | $772,331.60 | |
| Feb. 4, 2026 | Director | 2,602 | $45.02 | Sell | $117,142.04 | |
| Feb. 3, 2026 | Director | 12,528 | $45.27 | Sell | $567,142.56 | |
| Feb. 2, 2026 | Director | 830 | $45.00 | Sell | $37,350.00 | |
| Sept. 15, 2025 | COO | 16,400 | $36.46 | Sell | $597,944.00 | |
| Sept. 5, 2025 | COO | 13,389 | $35.66 | Sell | $477,451.74 | |
| Sept. 4, 2025 | COO | 85,271 | $35.52 | Sell | $3,028,825.92 | |
| Sept. 4, 2025 | Insider | 3,523 | $35.31 | Sell | $124,397.13 | |
| Sept. 3, 2025 | CAO | 11,000 | $34.84 | Sell | $383,240.00 | |
| Sept. 3, 2025 | COO | 15,091 | $35.50 | Sell | $535,730.50 | |
| Aug. 18, 2025 | COO | 16,200 | $33.77 | Sell | $547,074.00 | |
| Aug. 14, 2025 | Director | 78,233 | $33.09 | Sell | $2,588,729.97 | |
| Aug. 13, 2025 | Director | 50,129 | $33.32 | Sell | $1,670,298.28 | |
| Aug. 12, 2025 | Director | 49,407 | $32.40 | Sell | $1,600,786.80 | |
| Aug. 6, 2025 | Insider | 29,325 | $32.55 | Sell | $954,528.75 | |
| Aug. 5, 2025 | COO | 138,614 | $33.20 | Sell | $4,601,984.80 | |
| Aug. 4, 2025 | CAO | 17,000 | $32.35 | Sell | $549,950.00 | |
| Aug. 4, 2025 | CFO | 18,889 | $32.89 | Sell | $621,259.21 | |
| July 14, 2025 | COO | 18,900 | $28.72 | Sell | $542,808.00 | |
| June 16, 2025 | COO | 17,300 | $28.28 | Sell | $489,244.00 | |
| June 11, 2025 | COO | 45,042 | $30.51 | Sell | $1,374,231.42 | |
| June 11, 2025 | Director | 12,336 | $30.39 | Sell | $374,891.04 | |
| June 10, 2025 | COO | 15,506 | $30.46 | Sell | $472,312.76 | |
| June 10, 2025 | Director | 8,212 | $30.36 | Sell | $249,316.32 | |
| June 9, 2025 | COO | 10,319 | $30.38 | Sell | $313,491.22 | |
| June 9, 2025 | Director | 6,900 | $30.26 | Sell | $208,794.00 | |
| June 3, 2025 | CFO | 18,299 | $28.80 | Sell | $527,011.20 | |
| June 3, 2025 | Insider | 27,594 | $29.02 | Sell | $800,777.88 | |
| June 3, 2025 | CAO | 15,211 | $28.75 | Sell | $437,316.25 | |
| May 28, 2025 | CEO | 62,116 | $27.33 | Sell | $1,697,630.28 | |
| May 27, 2025 | CEO | 19,317 | $27.01 | Sell | $521,752.17 | |
| May 23, 2025 | CEO | 4,837 | $27.00 | Sell | $130,599.00 | |
| May 19, 2025 | COO | 12,000 | $26.41 | Sell | $316,920.00 | |
| May 13, 2025 | CEO | 2,872 | $27.03 | Sell | $77,630.16 | |
| May 8, 2025 | CEO | 101 | $27.00 | Sell | $2,727.00 | |
| May 7, 2025 | Insider | 200 | $27.00 | Sell | $5,400.00 | |
| May 7, 2025 | CAO | 17,647 | $26.69 | Sell | $470,998.43 | |
| May 5, 2025 | Insider | 6,272 | $28.00 | Sell | $175,616.00 | |
| May 1, 2025 | Insider | 23,234 | $28.02 | Sell | $651,016.68 | |
| April 30, 2025 | CFO | 21,254 | $26.95 | Sell | $572,795.30 | |
| April 29, 2025 | Insider | 64,035 | $25.21 | Sell | $1,614,322.35 | |
| April 21, 2025 | Insider | 18,259 | $20.29 | Sell | $370,475.11 | |
| April 14, 2025 | COO | 12,000 | $20.48 | Sell | $245,760.00 | |
| March 19, 2025 | CFO | 8,879 | $23.10 | Sell | $205,104.90 | |
| March 17, 2025 | CFO | 11,464 | $23.10 | Sell | $264,818.40 | |
| March 12, 2025 | CFO | 36,372 | $22.25 | Sell | $809,277.00 | |
| March 12, 2025 | CAO | 9,051 | $22.45 | Sell | $203,194.95 | |
| Feb. 10, 2025 | COO | 14,000 | $19.57 | Sell | $273,980.00 |
Insiders are both buying and selling Kiniksa Pharmaceuticals Ltd stock.
The insider traders at Kiniksa Pharmaceuticals Ltd are: Eben Tessari, Sanj K Patel, Mark Ragosa, John F Paolini, Michael R Megna, Barry D Quart, Ross Moat, Thomas W Beetham, Thomas Malley, Cormorant Asset Management, Lp, Bros. Advisors Lp Baker, James E Flynn, and Barry D. Quart
The most active insider trader at Kiniksa Pharmaceuticals Ltd is Eben Tessari with 18 trades.
Eben Tessari has sold the most Kiniksa Pharmaceuticals Ltd stock with a total value of $16,036,102.36.
Bros. Advisors Lp Baker has bought the most Kiniksa Pharmaceuticals Ltd stock with a total value of $108,000,000.00.
The most recent insider trade for Kiniksa Pharmaceuticals Ltd was on Feb. 12, 2026.
The single biggest insider buy for Kiniksa Pharmaceuticals Ltd was from Bros. Advisors Lp Baker with a total value of $54,000,000.00 on May 29, 2018.
The single biggest insider sell for Kiniksa Pharmaceuticals Ltd was from Eben Tessari with a total value of $4,601,984.80 on Aug. 5, 2025.
